Press Releases BetterLife Pharma Inc.

Equities

BETRF

CA08772P2026

Delayed OTC Markets Other stock markets 11:22:28 2024-04-29 am EDT			5-day change	1st Jan Change
0.0753 ^USD	-1.62%		+1.07%	+56.88%

Apr. 03	BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding	CI
Mar. 04	BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	Apr. 15	NE
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	Apr. 11	GL
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	Apr. 11	AQ
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	Apr. 03	GL
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001	Apr. 03	AQ
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	Mar. 04	GL
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University	Mar. 04	AQ
BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001	Jan. 02	GL
BetterLife Pharma : MANAGEMENT'S DISCUSSION AND ANALYSIS - Form 6-K	Dec. 29	PU
BetterLife Announces Closing of a Private Placement	Dec. 18	GL
BetterLife Announces Closing of a Private Placement	Dec. 18	AQ
BetterLife Pharma : MATERIAL CHANGE REPORT - Form 6-K	Nov. 30	PU
BetterLife Announces Extension of Warrants	Nov. 30	GL
BetterLife Announces Extension of Warrants	Nov. 30	AQ
US Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD Derivatives	Nov. 15	GL
BetterLife Pharma : MATERIAL CHANGE REPORT - Form 6-K	23-09-29	PU
BetterLife Pharma : MANAGEMENT’S DISCUSSION AND ANALYSIS - Form 6-K	23-09-28	PU
BetterLife Pharma to Host Investors Update Call on September 18, 2023	23-09-14	GL
BetterLife Pharma to Host Investors Update Call on September 18, 2023	23-09-14	AQ
BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001	23-09-12	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BetterLife Pharma Inc.

Equities

BETRF

CA08772P2026

Press Releases

Filters